Irradiation sterilization services market seen topping $5 billion by 2030

The irradiation sterilization services market is forecast to grow 13% annually through 2030 and surpass $5 billion, according to The Business Research Company. North America and the U.S. are expected to lead demand as medical device, pharmaceutical and infection-control needs push more sterilization work to gamma, x-ray and electron beam providers.

Why it matters: - The market sits inside the healthcare supply chain that keeps medical devices, pharmaceuticals and sterile packaging safe for use. - Faster growth in sterilization capacity can ease bottlenecks for manufacturers of surgical tools, implants, syringes and catheters. - The market is also gaining importance as regulators and buyers demand more validated, traceable sterilization processes.

What happened: - The Business Research Company said the irradiation sterilization services market is on track to top $5 billion by 2030. - The market is forecast to grow at a 13% compound annual growth rate through 2030. - North America is projected to be the largest regional market in 2030 at $2.4 billion, up from $1.4 billion in 2025. - The U.S. is expected to remain the dominant country, reaching $2.2 billion by 2030 from $1.2 billion in 2025. - Steris plc. held the largest global market share in 2025 at 13%.

The details: - Irradiation sterilization accounts for about 2% of the medical laboratory services market and about 0.05% of the broader healthcare services market. - Onsite sterilization is expected to remain the largest service model, representing 86% of the market, or about $5 billion in 2030. - The market is segmented by technology into gamma irradiation, x-ray irradiation and electron beam sterilization. - Applications include medical instruments, drugs, food, laboratory uses and other specialized areas. - North American growth is being driven by sterile medical device production, pharmaceutical output, strict infection-control rules and demand for contract sterilization services using gamma, electron beam and x-ray technologies. - U.S. growth is being supported by demand for sterile packaging and disposable medical products, a larger biopharmaceutical and biotechnology sector, more outsourcing and new irradiation facilities. - The report says rising sterilization demand could add about 1.8% annual growth to the market. - Technology advances are expected to add about 1.4% annual growth by improving dose precision, processing speed, quality control and automation. - Regulatory support is projected to contribute about 1.0% annual growth. - Onsite and offsite sterilization together are expected to add more than $2.4 billion in market value by 2030. - Onsite services are forecast to add $2 billion between 2025 and 2030. - Offsite services are forecast to add $0.4 billion over the same period. - The top 10 companies accounted for 27% of revenue in 2025, pointing to a moderately fragmented market. - Steris plc. had the largest share at 13%, followed by Sotera Health Company at 11%. - Other named share holders in 2025 included IBA Industrial, Ionisos SAS, BGS Beta-Gamma-Service, Scapa Sterilisation Services, ANSTO Health, E-BEAM Services, SteriTek and Microtrol Sterilisation Services.

Between the lines: - The market’s growth profile suggests sterilization is becoming a capacity and compliance issue, not just a back-end processing step. - Electron beam technology is emerging as a practical alternative to gamma irradiation, which could reshape facility investments and sourcing decisions. - Market concentration remains limited, leaving room for regional specialists and technology-focused entrants, even with high regulatory barriers. - The report’s own disclaimer says its figures are estimates and opinions, not definitive facts or investment advice.

What's next: - Companies are expected to keep investing in radiation-based sterilization technologies, new facilities and automated monitoring systems. - Growth opportunities are likely to center on combination products, complex devices, emerging-region manufacturing and x-ray irradiation adoption. - BGS US opened a 100,000-square-foot electron beam sterilization facility in Imperial, Pennsylvania, in August 2025, signaling more capacity additions ahead. - More strategic partnerships and regional expansions appear likely as demand rises for validated sterilization services in healthcare and life sciences.

The bottom line: - Irradiation sterilization is moving from niche infrastructure to a bigger strategic layer in healthcare manufacturing, with North America, the U.S. and Steris currently leading the pack.